Skip to main content
. 2020 Jun 22;15:156. doi: 10.1186/s13014-020-01601-8

Fig. 2.

Fig. 2

The overall survival (OS), local progression-free survival (LPFS), and distant metastasis-free survival (DMFS) graphs of the whole cohort. For the entire cohort, 2-year OS, LPFS, and DMFS rates were 69.0, 76.7, and 71.4%, respectively